Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 708 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is M  [Clear All Filters]
2004
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ.  2004.  Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages.. J Biol Chem. 279(18):18451-6.
Luo Q, Ma X, Wahl SM, Bieker JJ, Crossley M, Montaner LJ.  2004.  Activation and repression of interleukin-12 p40 transcription by erythroid Kruppel-like factor in macrophages.. J Biol Chem. 279(18):18451-6.
Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X.  2004.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.. Int J Cancer. 110(4):570-8.
Shi X, Liu J, Xiang Z, Mitsuhashi M, Wu RS, Ma X.  2004.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.. Int J Cancer. 110(4):570-8.
Shi X, Cao S, Mitsuhashi M, Xiang Z, Ma X.  2004.  Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.. J Immunol. 172(7):4111-22.
Shi X, Cao S, Mitsuhashi M, Xiang Z, Ma X.  2004.  Genome-wide analysis of molecular changes in IL-12-induced control of mammary carcinoma via IFN-gamma-independent mechanisms.. J Immunol. 172(7):4111-22.
Cao S, Xiang Z, Ma X.  2004.  Global gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary Carcinoma.. Cell Mol Immunol. 1(5):357-66.
Mitsuhashi M, Liu J, Cao S, Shi X, Ma X.  2004.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.. J Leukoc Biol. 76(2):322-32.
Mitsuhashi M, Liu J, Cao S, Shi X, Ma X.  2004.  Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.. J Leukoc Biol. 76(2):322-32.
Liu J, Xiang Z, Ma X.  2004.  Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma.. J Immunol. 173(2):1184-93.
Liu J, Guan X, Tamura T, Ozato K, Ma X.  2004.  Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein.. J Biol Chem. 279(53):55609-17.
Kim S, Elkon KB, Ma X.  2004.  Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells.. Immunity. 21(5):643-53.
2003
Bosoy D, Peng Y, I Mian S, Lue NF.  2003.  Conserved N-terminal motifs of telomerase reverse transcriptase required for ribonucleoprotein assembly in vivo.. J Biol Chem. 278(6):3882-90.
Lue NF, Lin Y-C, I Mian S.  2003.  A conserved telomerase motif within the catalytic domain of telomerase reverse transcriptase is specifically required for repeat addition processivity.. Mol Cell Biol. 23(23):8440-9.
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.
Murray HW, Moreira AL, Lu CM, DeVecchio JL, Matsuhashi M, Ma X, Heinzel FP.  2003.  Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. J Infect Dis. 188(3):458-64.
Liu J, Cao S, Herman LM, Ma X.  2003.  Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.. J Exp Med. 198(8):1265-76.
Shimono N, Morici L, Casali N, Cantrell S, Sidders B, Ehrt S, Riley LW.  2003.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.. Proc Natl Acad Sci U S A. 100(26):15918-23.
Xiang Z, Yang Y, Ma X, Ding W.  2003.  Microarray expression profiling: analysis and applications.. Curr Opin Drug Discov Devel. 6(3):384-95.
Dahlseid JN, Lew-Smith J, Lelivelt MJ, Enomoto S, Ford A, Desruisseaux M, McClellan M, Lue N, Culbertson MR, Berman J.  2003.  mRNAs encoding telomerase components and regulators are controlled by UPF genes in Saccharomyces cerevisiae.. Eukaryot Cell. 2(1):134-42.
Kim SJung, Gershov D, Ma X, Brot N, Elkon KB.  2003.  Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses.. Ann N Y Acad Sci. 987:68-78.
Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C et al..  2003.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.. J Exp Med. 198(5):693-704.
Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C et al..  2003.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.. J Exp Med. 198(5):693-704.